• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝集素、肽T-20和中和抗体对HIV-1包膜介导的细胞间融合的抑制作用。

Inhibition of HIV-1 Env-Mediated Cell-Cell Fusion by Lectins, Peptide T-20, and Neutralizing Antibodies.

作者信息

Yee Michael, Konopka Krystyna, Balzarini Jan, Düzgüneş Nejat

机构信息

Department of Biomedical Sciences, University of the Pacific Arthur A. Dugoni School of Dentistry, San Francisco, CA 94115, USA.

出版信息

Open Virol J. 2011;5:44-51. doi: 10.2174/1874357901105010044. Epub 2011 May 12.

DOI:10.2174/1874357901105010044
PMID:21660189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109660/
Abstract

BACKGROUND

Broadly cross-reactive, neutralizing human monoclonal antibodies, including 2F5, 2G12, 4E10 and IgG1 b12, can inhibit HIV-1 infection in vitro at very low concentrations. We examined the ability of these antibodies to inhibit cell-cell fusion between Clone69TRevEnv cells induced to express the viral envelope proteins, gp120/gp41 (Env), and highly CD4-positive SupT1 cells. The cells were loaded with green and red-orange cytoplasmic fluorophores, and fusion was monitored by fluorescence microscopy.

RESULTS

Cell-cell fusion was inhibited completely by the carbohydrate binding proteins (CBPs), Hippeastrum hybrid (Amaryllis) agglutinin (HHA), and Galanthus nivalis (Snowdrop) agglutinin (GNA), and by the peptide, T-20, at relatively low concentrations. Anti-gp120 and anti-gp41 antibodies, at concentrations much higher than those required for neutralization, were not particularly effective in inhibiting fusion. Monoclonal antibodies b12, m14 IgG and 2G12 had moderate inhibitory activity; the IC(50) of 2G12 was about 80 µg/ml. Antibodies 4E10 and 2F5 had no inhibitory activity at the concentrations tested.

CONCLUSIONS

These observations raise concerns about the ability of neutralizing antibodies to inhibit the spread of viral genetic material from infected cells to uninfected cells via cell-cell fusion. The interaction of gp120/gp41 with cell membrane CD4 may be different in cell-cell and virus-cell membrane fusion reactions, and may explain the differential effects of antibodies in these two systems. The fluorescence assay described here may be useful in high throughput screening of potential HIV fusion inhibitors.

摘要

背景

广泛交叉反应的中和性人单克隆抗体,包括2F5、2G12、4E10和IgG1 b12,能在极低浓度下体外抑制HIV - 1感染。我们检测了这些抗体抑制诱导表达病毒包膜蛋白gp120/gp41(Env)的Clone69TRevEnv细胞与高CD4阳性的SupT1细胞之间细胞 - 细胞融合的能力。细胞加载了绿色和红橙色细胞质荧光团,通过荧光显微镜监测融合情况。

结果

碳水化合物结合蛋白(CBP),即朱顶红(孤挺花)凝集素(HHA)和雪花莲凝集素(GNA),以及肽T - 20在相对低浓度下就能完全抑制细胞 - 细胞融合。抗gp120和抗gp41抗体在浓度远高于中和所需浓度时,对抑制融合并非特别有效。单克隆抗体b12、m14 IgG和2G12具有中等抑制活性;2G12的半数抑制浓度(IC50)约为80μg/ml。抗体4E10和2F5在测试浓度下无抑制活性。

结论

这些观察结果引发了对于中和抗体通过细胞 - 细胞融合抑制病毒遗传物质从感染细胞传播至未感染细胞能力的担忧。gp120/gp41与细胞膜CD4的相互作用在细胞 - 细胞和病毒 - 细胞膜融合反应中可能不同,这或许可以解释抗体在这两个系统中的不同作用效果。此处描述的荧光测定法可能有助于高通量筛选潜在的HIV融合抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/c218148fd492/TOVJ-5-44_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/86fe2cb8bad6/TOVJ-5-44_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/575c4e7b5148/TOVJ-5-44_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/9ad09ad1c753/TOVJ-5-44_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/c218148fd492/TOVJ-5-44_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/86fe2cb8bad6/TOVJ-5-44_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/575c4e7b5148/TOVJ-5-44_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/9ad09ad1c753/TOVJ-5-44_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415e/3109660/c218148fd492/TOVJ-5-44_F4.jpg

相似文献

1
Inhibition of HIV-1 Env-Mediated Cell-Cell Fusion by Lectins, Peptide T-20, and Neutralizing Antibodies.凝集素、肽T-20和中和抗体对HIV-1包膜介导的细胞间融合的抑制作用。
Open Virol J. 2011;5:44-51. doi: 10.2174/1874357901105010044. Epub 2011 May 12.
2
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).针对人类免疫缺陷病毒1型包膜糖蛋白gp120(单克隆抗体2G12)和gp41(单克隆抗体4E10和2F5)的人源单克隆抗体的长期多剂量药代动力学
Antimicrob Agents Chemother. 2006 May;50(5):1773-9. doi: 10.1128/AAC.50.5.1773-1779.2006.
3
Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.基于CD4的分子与针对gp120或gp41的抗体联合对HIV-1包膜介导的细胞融合的协同抑制作用。
AIDS Res Hum Retroviruses. 1993 Jul;9(7):581-7. doi: 10.1089/aid.1993.9.581.
4
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.一种新型交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体的鉴定与表征
J Virol. 2004 Sep;78(17):9233-42. doi: 10.1128/JVI.78.17.9233-9242.2004.
5
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.在朱顶红和雪花莲的甘露糖特异性植物凝集素的选择压力下,HIV-1 gp120中糖基化位点显著减少。
Mol Pharmacol. 2005 May;67(5):1556-65. doi: 10.1124/mol.104.005082. Epub 2005 Feb 17.
6
HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.1型人类免疫缺陷病毒包膜前体的切割状态影响中和性和非中和性gp41抗体的识别。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.
7
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.通过筛选免疫人噬菌体文库以对抗从具有广泛HIV-1中和抗体的患者(R2)分离出的包膜糖蛋白(gp140)而选择的交叉反应性HIV-1中和单克隆抗体。
Virology. 2007 Jun 20;363(1):79-90. doi: 10.1016/j.virol.2007.01.015. Epub 2007 Feb 15.
8
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.细胞间融合过程中人类免疫缺陷病毒跨膜糖蛋白的抗原特性
J Virol. 2002 Dec;76(23):12123-34. doi: 10.1128/jvi.76.23.12123-12134.2002.
9
Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand.对来自泰国中部一名感染了人类免疫缺陷病毒1型(HIV-1)患者的含有CRF01_AE env基因的重组HIV-1进行的表型研究。
Microbes Infect. 2009 Mar;11(3):334-43. doi: 10.1016/j.micinf.2008.12.008. Epub 2008 Dec 27.
10
Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.评估多反应性抗体4E10和2F5在T细胞与HIV黏附后使gp41三聚体失活的概率。
PLoS Comput Biol. 2014 Jan 30;10(1):e1003431. doi: 10.1371/journal.pcbi.1003431. eCollection 2014 Jan.

引用本文的文献

1
High-Level Production of Recombinant Snowdrop Lectin in Sugarcane and Energy Cane.甘蔗和能源甘蔗中重组雪花莲凝集素的高水平生产。
Front Bioeng Biotechnol. 2020 Aug 18;8:977. doi: 10.3389/fbioe.2020.00977. eCollection 2020.
2
Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells.根除人类免疫缺陷病毒1型(HIV-1)感染细胞。
Pharmaceutics. 2019 Jun 1;11(6):255. doi: 10.3390/pharmaceutics11060255.
3
An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

本文引用的文献

1
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.包膜的合理设计鉴定出针对 HIV-1 的广泛中和人源单克隆抗体。
Science. 2010 Aug 13;329(5993):856-61. doi: 10.1126/science.1187659. Epub 2010 Jul 8.
2
Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.碳水化合物结合剂作为抗包膜病毒治疗剂的潜力。
Med Res Rev. 2012 Mar;32(2):349-87. doi: 10.1002/med.20216. Epub 2010 Jun 23.
3
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.
蓝绿菌素-N重组蛋白表达系统的更新及临床前开发面临的挑战。
Bioimpacts. 2018;8(2):139-151. doi: 10.15171/bi.2018.16. Epub 2017 Nov 16.
4
The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.来自HIV-1毒株HXB2和JRFL的gp41膜近端外部区域对丙氨酸突变具有不同的敏感性。
Biochemistry. 2015 Mar 3;54(8):1681-93. doi: 10.1021/bi501171r. Epub 2015 Feb 19.
5
Lectins with anti-HIV activity: a review.具有抗HIV活性的凝集素:综述
Molecules. 2015 Jan 6;20(1):648-68. doi: 10.3390/molecules20010648.
6
Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition.用于评估HIV中和及细胞间融合抑制的基于图像的自动化检测方法。
BMC Infect Dis. 2014 Aug 30;14:472. doi: 10.1186/1471-2334-14-472.
7
Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41.通过对 HIV gp41 的 C 七肽重复序列的扫描诱变揭示了株间细胞融合和病毒进入的显著差异。
Biochemistry. 2013 May 21;52(20):3552-63. doi: 10.1021/bi400201h. Epub 2013 May 7.
8
Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins.雪绒花凝集素(GNA)相关凝集素的抗肿瘤和抗病毒活性。
Glycoconj J. 2013 Apr;30(3):269-79. doi: 10.1007/s10719-012-9440-z. Epub 2012 Aug 15.
一位非洲捐赠者体内广泛且强效的中和抗体揭示了一个新的HIV-1疫苗靶点。
Science. 2009 Oct 9;326(5950):285-9. doi: 10.1126/science.1178746. Epub 2009 Sep 3.
4
Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors.人源单克隆抗体及工程化抗体结构域作为HIV-1进入抑制剂
Curr Opin HIV AIDS. 2009 Mar;4(2):112-7. doi: 10.1097/COH.0b013e328322f95e.
5
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm.病毒蛋白介导融合的共同原则及中间体:以HIV-1为例
Retrovirology. 2008 Dec 10;5:111. doi: 10.1186/1742-4690-5-111.
6
Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.人类免疫缺陷病毒1型(HIV-1)对具有广泛HIV-1中和活性的抗碳水化合物抗体2G12的耐药性。
Virology. 2007 Apr 10;360(2):294-304. doi: 10.1016/j.virol.2006.10.027. Epub 2006 Nov 21.
7
Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.在低CCR5表面浓度下抗体对HIV-1中和作用的增强疗效。
Biochem Biophys Res Commun. 2006 Sep 29;348(3):1107-15. doi: 10.1016/j.bbrc.2006.07.163. Epub 2006 Aug 4.
8
Inhibition of HIV entry by carbohydrate-binding proteins.碳水化合物结合蛋白对HIV进入的抑制作用。
Antiviral Res. 2006 Sep;71(2-3):237-47. doi: 10.1016/j.antiviral.2006.02.004. Epub 2006 Mar 9.
9
Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.结构改变的肽揭示了N端七肽重复序列结合及稳定性在HIV-1肽DP178抑制作用中的重要作用。
J Biol Chem. 2006 Apr 7;281(14):9005-10. doi: 10.1074/jbc.M512475200. Epub 2006 Feb 1.
10
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.一种新型交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体的鉴定与表征
J Virol. 2004 Sep;78(17):9233-42. doi: 10.1128/JVI.78.17.9233-9242.2004.